HomeNewsWorldWHO-led team expected in China in January to probe COVID-19 origins

WHO-led team expected in China in January to probe COVID-19 origins

The United States, which has accused China of having hidden the outbreak’s extent, has called for a “transparent” WHO-led investigation and criticised its terms, which allowed Chinese scientists to do the first phase of preliminary research.

December 17, 2020 / 07:54 IST
Story continues below Advertisement
Source: Reuters
Source: Reuters

An international mission led by the World Health Organization (WHO) is expected to go to China in the first week of January to investigate the origins of the virus that sparked the COVID-19 pandemic, a member and diplomats told Reuters on Wednesday.
The United States, which has accused China of having hidden the outbreak’s extent, has called for a “transparent” WHO-led investigation and criticised its terms, which allowed Chinese scientists to do the first phase of preliminary research.

China reported the first cases of a pneumonia of unknown cause in Wuhan, central China, to the WHO on Dec. 31 and closed a market where the novel coronavirus is believed to have emerged.

Story continues below Advertisement

Health ministers called on the WHO in May to identify the source of the virus and how it crossed the species barrier.

Now a team of 12-15 international experts is finally preparing to go to Wuhan to examine evidence, including human and animal samples collected by Chinese researchers, and to build on their initial studies.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show